InvestorsHub Logo
Followers 155
Posts 2647
Boards Moderated 0
Alias Born 01/29/2004

Re: McMagyar post# 83370

Sunday, 12/11/2016 3:12:55 PM

Sunday, December 11, 2016 3:12:55 PM

Post# of 462643
Feel free to copy, post, and distribute my brief comments on the recent CDAT presentation. It's in the public domain. I posted it here so as to clearly lay out the implications of the new study data.

I’m a retired biologist and have done a good deal of technical writing, primarily in the presentation of complex biological and ecological topics to lay, public audiences. Many (well, most) of my professional colleagues are inexperienced and not always artful in presenting complex scientific topics to lay audiences. My teaching and publishing experiences have allowed a good degree of success in such endeavors. I hope the posting can be of use.

Yes, the several (not just 2-73) Anavex stories need to rise to public awareness. Out of curiosity, I just did a Bing websearch on “Anavex 2-73.” Merely some old, out-of-date URLs. Not a word on the revolutionizing new data, nor their profound implications for a) Alzheimer’s patients, b) medical care and cost systems, c) insurance implications, nor d) corporate or personal investment implications. Nothing. Not a word.

I’m certain it won’t be just A2-73 against Alzheimer’s. Very strong preliminary evidence of similar or exceeding outcomes will be forthcoming for Parkinson’s disease. Add amyotrophic lateral sclerosis (Lou Gehrig’s disease) and multiple sclerosis (and even others; cancers, epilepsy, psychiatrics), and the Anavex story will actually exceed the penicillin and modern antibiotics stories of the last century.

Hope I might be able to assist in getting the new stories out. I note with a bit of a chuckle that one of my similar postings a few months ago, after the earlier Anavex study announcement went out, got posted in the highlights section, but then quickly disappeared as the market did not respond as aggressively as my conjectures suggested they might. I was not premature in those; they were merely not fully understood at the time. The data for lay readers were insufficient. No longer. The recent data plottings, showing stable or increased cognition trends validate my earlier notions on Anavex.

Let me know how I can help in getting the stories and messages to the right people and places.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News